Equity Analysis

Quarterly Results

    Wanbury Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    524212
    INE107F01022
    11.8265514
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    WANBURY
    36.31
    666.39
    EPS(TTM)
    Face Value()
    Div & Yield %:
    5.6
    10
    0
     
Quarters
(RupeeIcon Cr)
ParticularsDec 2024Sep 2024Jun 2024
Gross Sales133.45161.19131.11
Other Operating Income0.000.000.00
Other Income 0.841.630.94
Total Income134.29162.82132.05
Total Expenditure 119.51141.18120.13
PBIDT14.7821.6411.92
Interest 10.1710.157.59
PBDT4.6211.494.33
Depreciation3.323.323.29
Tax0.000.000.00
Fringe Benefit Tax0.000.000.00
Deferred Tax0.070.150.00
Reported Profit After Tax1.228.021.04
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item1.228.021.04
EPS (Unit Curr.)0.382.440.32
EPS (Adj) (Unit Curr.)0.382.440.32
Calculated EPS (Unit Curr.)0.372.450.32
Calculated EPS (Adj) (Unit Curr.)0.372.450.32
Calculated EPS (Ann.) (Unit Curr.)1.499.791.27
Calculated EPS (Adj) (Ann.) (Unit Curr.)1.499.791.27
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity32.7732.7632.75
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)11.0813.439.09
PBDTM(%)3.467.133.30
PATM(%)0.914.980.79
Dividend Per Share(Rs)0.000.000.00
Diluted EPS0.352.340.31